Immunoprecise Antibodies Stock Analysis

Immunoprecise Stock Analysis Notes

About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.46. Some equities with similar Price to Book (P/B) outperform the market in the long run. Immunoprecise Antibodies recorded a loss per share of 0.77. The entity last dividend was issued on the 23rd of November 2020. The firm had 1:5 split on the 23rd of November 2020. ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada. Immunoprecise Antibodies is traded on NASDAQ Exchange in the United States. To learn more about Immunoprecise Antibodies call Jennifer Bath at 250 483 0308 or check out https://www.ipatherapeutics.com.

Immunoprecise Antibodies Investment Alerts

Immunoprecise Antibodies Upcoming and Recent Events

Immunoprecise Largest EPS Surprises

View All Earnings Estimates

Immunoprecise Stock Institutional Investors

Note, although Immunoprecise Antibodies' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immunoprecise Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 10.84 M.

Immunoprecise Profitablity

The company has Net Profit Margin of (1.15) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.86) %, which entails that for every $100 of revenue, it lost $0.86.

Management Efficiency

Immunoprecise Antibodies has Return on Asset of (0.1345) % which means that on every $100 spent on assets, it lost $0.1345. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.6404) %, meaning that it generated no profit with money invested by stockholders. Immunoprecise Antibodies' management efficiency ratios could be used to measure how well Immunoprecise Antibodies manages its routine affairs as well as how well it operates its assets and liabilities. At present, Immunoprecise Antibodies' Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.30, whereas Return On Tangible Assets are forecasted to decline to (1.39). At present, Immunoprecise Antibodies' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 50.9 M, whereas Total Current Assets are forecasted to decline to about 6 M.

Technical Drivers

As of the 23rd of November, Immunoprecise Antibodies retains the Market Risk Adjusted Performance of 0.7194, risk adjusted performance of (0.11), and Standard Deviation of 6.51. Immunoprecise Antibodies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Immunoprecise Antibodies Price Movement Analysis

Immunoprecise Antibodies Outstanding Bonds

Immunoprecise Antibodies Predictive Daily Indicators

Immunoprecise Antibodies Forecast Models

Immunoprecise Antibodies' time-series forecasting models are one of many Immunoprecise Antibodies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immunoprecise Antibodies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Immunoprecise Antibodies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immunoprecise shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immunoprecise Antibodies. By using and applying Immunoprecise Stock analysis, traders can create a robust methodology for identifying Immunoprecise entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immunoprecise analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immunoprecise analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Immunoprecise Antibodies stock analysis indicators help investors evaluate how Immunoprecise Antibodies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Immunoprecise Antibodies shares will generate the highest return on investment. By understating and applying Immunoprecise Antibodies stock analysis, traders can identify Immunoprecise Antibodies position entry and exit signals to maximize returns.

When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.